Champagne, Ronald

Champagne, Ronald was paid $1.15M by Medicaid between Jan 2018 and Dec 2024, across 93 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 24% of everything it billed.

Compared with peers

Next to other Anatomic Pathology & Clinical Pathology Physician providers in Illinois

Rank by total paid#59 of 398

Median peer was paid$66K

This provider vs. median18×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	19,084	$75K
2019	23,103	$99K
2020	14,165	$61K
2021	14,872	$333K
2022	13,247	$196K
2023	15,034	$132K
2024incomplete	37,325	$256K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	24%	5,398	4,261	$280K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	9.1%	2,746	2,259	$105K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	6.9%	973	948	$80K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	6.8%	457	428	$78K
80053	Comprehensive metabolic panel	5.7%	12,948	11,087	$65K
88305	Level IV - Surgical pathology, gross and microscopic examination	5.4%	1,630	1,574	$63K
87086	Culture, bacterial; quantitative colony count, urine	3.7%	8,692	7,861	$43K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	3.7%	14,949	11,934	$42K
84443	Thyroid stimulating hormone (TSH)	3.2%	4,728	4,527	$36K
87081		1.9%	7,447	7,121	$21K
0240U		1.8%	274	270	$20K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	1.7%	1,084	1,056	$19K

81 more codes

84439		1.6%	4,468	$19K
80048	Basic metabolic panel (calcium, ionized)	1.3%	3,714	$15K
83735		1.3%	4,466	$14K
87186		1.2%	2,453	$14K
80306		1.1%	2,127	$12K
82607		1.1%	2,045	$12K
83690		1.0%	3,566	$12K
87040		<1%	1,062	$11K
87808		<1%	1,344	$10K
80061	Lipid panel	<1%	3,028	$10K
87088		<1%	1,738	$9K
83605		<1%	1,791	$9K
82803		<1%	1,217	$9K
87507		<1%	42	$7K
81001		<1%	5,170	$7K
84484		<1%	1,695	$7K
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	28	$7K
83036	Hemoglobin; glycosylated (A1C)	<1%	1,983	$6K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	738	$6K
83540		<1%	1,843	$6K
86850		<1%	2,040	$6K
85027		<1%	1,931	$5K
82728		<1%	1,148	$5K
81025		<1%	2,080	$5K
84466		<1%	1,078	$5K
86901		<1%	2,167	$5K
83874		<1%	741	$4K
85610		<1%	2,241	$4K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	558	$4K
87420		<1%	504	$4K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	104	$4K
86900		<1%	2,183	$4K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	250	$4K
86592		<1%	1,793	$3K
84702		<1%	755	$3K
83880		<1%	240	$3K
87210		<1%	1,214	$3K
86140		<1%	1,241	$3K
81003		<1%	2,142	$2K
85379		<1%	421	$2K
88304		<1%	59	$1K
87486		<1%	67	$1K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	53	$1K
85652		<1%	830	$1K
85651		<1%	463	$1K
87205		<1%	580	$1K
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	107	$941.60
84703		<1%	232	$822.86
80069		<1%	192	$798.43
81015		<1%	588	$760.59
85018		<1%	464	$525.76
82570		<1%	209	$477.65
82962		<1%	378	$464.93
85730		<1%	149	$464.12
87430		<1%	53	$407.78
83655		<1%	63	$356.89
82044		<1%	179	$352.63
87184		<1%	66	$346.50
83498		<1%	38	$343.70
82950		<1%	149	$342.51
84156		<1%	226	$257.05
0352U		<1%	297	$231.42
83519		<1%	37	$211.20
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	12	$207.10
82947		<1%	103	$181.45
83550		<1%	38	$162.64
86430		<1%	39	$117.74
85660		<1%	49	$102.52
82776		<1%	25	$95.08
84460		<1%	83	$91.15
82150		<1%	28	$89.32
84030		<1%	37	$84.16
84550		<1%	39	$81.65
82746		<1%	14	$77.77
84450		<1%	82	$72.79
86308		<1%	30	$72.00
88720		<1%	19	$41.80
85007		<1%	21	$35.00
81002		<1%	12	$15.60
80320		0%	33	$0.00
80329		0%	12	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.